Afib Risk Lower With ApoA1: Finnish Study Beats LDL, TG

A new Finnish study shows that higher ApoA1 levels are linked with a lower risk of atrial fibrillation, offering fresh insight into how protective lipoproteins may help stabilize heart rhythm.

🎧 ▶️ Press play below to listen.

🇨🇳 中文（简体）

一项来自芬兰的新研究发现，较高的 ApoA1 水平与更低的房颤风险相关，为保护性脂蛋白在维持心律稳定中的作用提供了新的证据。

请按下方的播放按钮收听。

Do you sometimes feel your heart racing, fluttering, or skipping a beat—but dismiss it as nothing? You may actually have atrial fibrillation (Afib) and not even know it. Afib is the most common sustained heart rhythm problem, and it can be silent for years before causing life-threatening complications.

Why should you care? Because Afib isn’t just about an irregular heartbeat. Left untreated, it can lead to blood clots, strokes, heart failure, and even a type of memory loss called multi-infarct dementia. Many people discover they have Afib only after a serious medical emergency.

That’s why new research from Finland is so important. It suggests that certain blood proteins—called apolipoproteins—may help predict who is more likely to develop Afib, giving people a chance to act before tragedy strikes.

What Is Atrial Fibrillation and Who Gets It?

Atrial fibrillation, or Afib, happens when the top chambers of your heart (the atria) send out chaotic electrical signals. Instead of a smooth, steady beat, the heart quivers or races irregularly.

Sometimes it feels like a flutter in the chest, sometimes like your heart is pounding hard, and sometimes you feel nothing at all. That’s why Afib is often called a “silent” condition.

How Many People Have Afib?

United States: More than 6 million adults are living with Afib today. By 2050, experts expect that number to double to 12 million.
Worldwide: About 33 million people already live with Afib, and Europe alone is expected to have nearly 18 million cases by 2060.

Types of Afib

Paroxysmal Afib: This kind comes and goes. Episodes can last minutes to days before the heart resets itself.
Persistent or Chronic Afib: This form doesn’t go away on its own and often needs medical treatment to restore rhythm.

Atrial fibrillation (AFib) isn’t just common—it’s dangerous. Even short, unnoticed episodes raise your risk of serious health problems like a brain stroke down the road.

Afib can cause a stroke — Afib forms blood clots in the heart that travel to the brain to cause a stroke

How Afib Is Diagnosed

Afib can be tricky to detect. Many people don’t feel any symptoms, and even when they do, the irregular heartbeat may come and go.

Electrocardiogram (EKG/ECG): This is the simplest test. Sticky pads placed on your chest record your heart’s electrical activity for a few seconds. If Afib is ongoing at that moment, the EKG will show it immediately.

The problem with paroxysmal Afib: If your Afib comes and goes (paroxysmal), it may not appear during those few seconds the EKG is running. That means the test can look normal even when you do have Afib.

Holter monitor: If your doctor suspects Afib but it doesn’t show on a standard EKG, you may be asked to wear a Holter monitor. This records your heart rhythm continuously for 24–48 hours.

Event monitor: For people with less frequent symptoms, an event monitor can be worn for weeks. You press a button when you feel palpitations, and the device records your heart’s rhythm before, during, and after the episode.

In short, a quick EKG may catch persistent AFib, but more detailed monitoring is often needed to uncover paroxysmal AFib.

Why Afib Is Dangerous

Afib is more than just an irregular heartbeat—it changes the way blood flows inside the heart. Because the atria quiver instead of pumping normally, blood can pool and form clots. Those clots can then travel to the brain, causing a stroke. In fact, Afib increases the risk of stroke by about five times compared to someone without it.

How Afib Can Cause Dementia

Not every clot causes a major stroke you can see right away. Many people with Afib experience small, silent strokes that go unnoticed. Over time, these repeated injuries can add up and lead to multi-infarct dementia—a gradual decline in memory, focus, and thinking skills caused by multiple small brain infarcts.

Challenges in Treating Afib

Doctors use different approaches to control Afib:

Some patients may need cardioversion—an electric shock or medication to reset the heart rhythm.
Many need anticoagulants (blood thinners) to prevent clots. While lifesaving, these drugs also carry risks.

The Double-Edged Sword of Blood Thinners

This is something I’ve seen many times working in the emergency room. If someone on blood thinners needs urgent surgery, it often has to be delayed until the medication is reversed—precious hours that can make a difference. On the other hand, if a person with Afib has high blood pressure and suffers a brain bleed, the bleeding can be much worse when they are on anticoagulants. It’s a constant balance between reducing stroke risk and preventing dangerous bleeding.

The Finnish Study: ApoA1 and Afib Risk

In 2022, researchers from Finland published an important study in the Journal of Clinical Lipidology. It came from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD).

KIHD is a large-scale project that has followed men in Eastern Finland for decades to understand heart disease better.

Who Was Studied

A total of 2,533 men, aged 42–60, were enrolled.
They were followed for an average of 22 years.
During that time, nearly 600 people developed Afib.

What the Researchers Found

The scientists measured different kinds of blood fats and proteins at the start of the study. They discovered something surprising:

Higher levels of HDL (“good cholesterol”) and ApoA1 were linked with a lower risk of developing Afib.
ApoA1 is the main protein found in HDL particles. It helps clear cholesterol from the body and has anti-inflammatory effects.
Other blood fats—including total cholesterol, LDL, triglycerides, and ApoB—did not show a meaningful link to Afib risk.

This is important for patients and doctors. Imagine a patient with paroxysmal Afib—episodes that come and go. If that patient gets a routine cholesterol panel (total cholesterol, LDL, triglycerides) and a standard EKG, and both come back normal, the conclusion might be: “Everything looks fine.”

But that would be misleading.

A short EKG strip can miss paroxysmal Afib if the heart happens to be beating normally at that moment.
A basic cholesterol test cannot reveal the risk because those three numbers don’t track with Afib.

In reality, the patient still has Afib episodes and remains at risk. Only extended monitoring (like a Holter or event monitor) and more detailed lab markers (like ApoA1 and HDL) tell the full story.

Why It Matters

This study suggests that not all cholesterol measurements tell the full story. Standard tests like “total cholesterol,” “LDL cholesterol,” and “triglycerides” may come back normal, but they miss the bigger picture.

ApoA1 and HDL appear to play a protective role against Afib, possibly by reducing inflammation and maintaining healthier blood vessels.

Patient Example: When Tests Look Normal — But Risk Isn’t Gone

Meet Mr. Allen, a 68-year-old retired teacher. He has no apparent symptoms most days, except for occasional fatigue or mild palpitations every few weeks, but nothing dramatic. His routine blood work shows:

Total cholesterol = 180 mg/dL (normal)
LDL (“bad cholesterol”) = 100 mg/dL (borderline, but nothing alarming)
Triglycerides = 120 mg/dL (within safe range)

He also has a standard EKG during his yearly physical, which is entirely normal. Since everything appears to be fine, both he and his doctor are reassured.

A few months later, Mr. Allen suffers an ischemic stroke — part of the brain loses blood flow due to a clot. After imaging and standard work-ups, no cause is identified: no carotid artery stenosis, no obvious heart disease, no clotting disorder, no clear source.

This is called a cryptogenic stroke — meaning a stroke whose cause remains unknown even after usual testing.

Cryptogenic strokes are not rare. In fact, 30%–40% of all ischemic strokes fall into this category, and many are later found to be linked to hidden Afib once long-term heart monitoring is done.

That means thousands of people every year are reassured by “normal” tests, only to face a devastating event that could have been prevented.

Blood Tests Meaning

When you get a cholesterol test, the results often look like a confusing alphabet soup. Here’s what the key terms mean in plain language:

ApoA1 – The main protein in HDL, often called the “good cholesterol.” It helps carry cholesterol out of your arteries and has anti-inflammatory effects. Higher ApoA1 levels are linked with a lower risk of Afib.

ApoB – The main protein in LDL and VLDL particles. Think of it as a “particle count” of the bad cholesterol carriers. More ApoB means more risk for plaque buildup in arteries.

HDL-C (High-Density Lipoprotein Cholesterol) – Known as the “good cholesterol.” It picks up extra cholesterol and carries it back to the liver for disposal.

LDL-C (Low-Density Lipoprotein Cholesterol) – Often called “bad cholesterol.” These particles deliver cholesterol to tissues, but too much can lead to plaque buildup in arteries.

Total Cholesterol (TC) – A combined measure of HDL, LDL, and other cholesterol fractions. It doesn’t tell the full story on its own.

Triglycerides (TG) – A type of fat in your blood that comes from food and excess calories. High levels are linked to heart disease, but in this study they didn’t predict Afib.

In short, ApoA1 and HDL are protective. ApoB and LDL are risky. However, when it comes to Afib specifically, this study revealed that ApoA1 and HDL are the most important factors to monitor.

How to Raise ApoA1 Naturally

The good news is that you can influence your ApoA1 levels with daily choices. While some medications are being studied to boost ApoA1, the safest and most proven way is through lifestyle.

1. Get Moving

Regular physical activity—especially aerobic exercise like brisk walking, cycling, or swimming—helps increase both HDL and ApoA1. Strength training adds even more benefit.

2. Eat the Right Fats

Omega-3 fatty acids from fish, flaxseed, and walnuts can support healthy HDL.
Olive oil and nuts (like almonds and pistachios) also raise ApoA1.
Avoid trans fats and limit processed foods, which do the opposite.

3. Maintain a Healthy Weight

Excess body fat can lower ApoA1. Gradual, sustainable weight loss improves cholesterol balance and heart health.

4. Avoid Alcohol

Small amounts of red wine or other alcohol have been linked with slightly higher HDL and ApoA1. But the risks of alcohol can outweigh the benefits, so this isn’t a recommended strategy for everyone.

5. Don’t Smoke

Smoking lowers ApoA1 and damages the cardiovascular system. Quitting allows your HDL and ApoA1 to rebound over time.

Recognizing Stroke Quickly

Since Afib greatly increases the risk of stroke, it’s essential to know the warning signs.

Doctors and stroke experts use the simple acronym F.A.S.T. to help people remember what to look for and what to do in case of a stroke. The image below shows how you can spot a stroke in progress—and why every second counts.

A igh ApoA1 and HDL can prevent a stroke

From Awareness to Action

Knowing the warning signs of stroke is vital, especially since Afib makes strokes more likely and more severe. But awareness alone isn’t enough—you also need to lower your risk before these emergencies happen.

That’s where the study findings, lifestyle choices, and proactive medical care come together.

Takeaway and Call to Action

Atrial fibrillation is far more common—and far more dangerous—than most people realize. Millions of people walk around with Afib without knowing it, until it leads to a stroke, dementia, or a trip to the emergency room.

This new study from Finland adds another layer to the story: people with higher levels of ApoA1 and HDL cholesterol had a lower risk of developing Afib. Unlike total cholesterol or LDL, these markers may give better insight into who is protected.

The encouraging part is that you can take steps right now to raise your ApoA1 naturally—by exercising, eating healthier fats, managing your weight, and staying smoke-free. These aren’t just numbers on a lab test; they are habits that can protect your brain, your heart, and your future.

As someone who has seen the emergencies of Afib firsthand in the ER—strokes, bleeding complications, and delayed surgeries—I can tell you this: don’t wait until it’s too late.

If you have risk factors or symptoms, talk with your doctor, get checked, and make the lifestyle changes that lower your risk. Your brain and heart will thank you.

Don’t Get Sick!

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.

References:

Tajik B, Tuomainen TP, Jarroch R, Kauhanen J, Lip GYH, Isanejad M. Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). J Clin Lipidol. 2022 Jul-Aug;16(4):447-454. doi: 10.1016/j.jacl.2022.04.003. Epub 2022 Apr 26. PMID: 35525793. https://pubmed.ncbi.nlm.nih.gov/35525793/
Benjamin, Emelia J., et al. “Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study.” Circulation, vol. 98, no. 10, 1998, pp. 946–52. https://www.ahajournals.org/doi/10.1161/01.cir.98.10.946
Chugh, Sumeet S., et al. “Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study.” Circulation, vol. 129, no. 8, 2014, pp. 837–47. https://pubmed.ncbi.nlm.nih.gov/24345399/
Kleindorfer, Dawn O., et al. “2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline from the American Heart Association/American Stroke Association.” Stroke, vol. 52, no. 7, 2021, pp. e364–e467. https://www.ahajournals.org/doi/10.1161/STR.0000000000000375
Sanna, T., et al. “Cryptogenic Stroke and Underlying Atrial Fibrillation.” New England Journal of Medicine, vol. 370, no. 26, 2014, pp. 2478–86. https://www.nejm.org/doi/full/10.1056/NEJMoa1313600
Saver, Jeffrey L. “Cryptogenic Stroke.” New England Journal of Medicine, vol. 374, no. 21, 2016, pp. 2065–74. https://www.nejm.org/doi/abs/10.1056/NEJMcp1503946

Image credits:

Stroke By Blausen Medical Communications, Inc. – see ticket for details, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=26986798
FAST mnemonic By U.S. National Center for Chronic Disease Prevention and Health Promotion – This file was derived from: Know the Facts About Stroke.pdf, Public Domain, https://commons.wikimedia.org/w/index.php?curid=146520107

As an Amazon Associate, I earn from qualifying purchases

Discover more from Don't Get Sick!

Subscribe to get the latest posts sent to your email.

Afib Risk Lower With ApoA1: New Finnish Study Findings

ApoA1 Outperforms LDL and Triglycerides in Predicting Atrial Fibrillation Risk